IL13RA1 and posterior cortical atrophy: In this study, we designed a series of functional and molecular assays to characterize the role of IL13Rα1 in PCa, and found that IL13Rα1-mediated glycolytic inhibition was a potential treatment for PCa, especially CRPC.